Text Size
3708 studies found for:    Lung Diseases, Obstructive: Clinical trials

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Arformoterol;   Drug: Placebo
22 Completed
Has Results 		A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
Conditions: Asthma;   Coronary Artery Disease;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Regadenoson;   Drug: Placebo
23 Completed
Has Results 		A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
24 Completed A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: 125/25 mcg once-daily;   Drug: 125mcg once-daily;   Drug: Placebo once-daily
25 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg
26 Completed A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: MEDI2338
27 Completed GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: fluticasone propionate/salmeterol combination DISKUS
28 Completed
Has Results 		Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD1236;   Drug: Placebo
29 Terminated
Has Results 		A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
Conditions: Diabetes Mellitus;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Subcutaneous Insulin;   Drug: Inhaled Insulin
30 Not yet recruiting Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: glycopyrronium bromide
31 Completed
Has Results 		Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol 150 μg capsules;   Drug: Indacaterol 300 μg capsules;   Drug: Placebo capsules
32 Completed A Study of the Efficacy and Safety of EP-101 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: COPD
Interventions: Drug: Placebo;   Drug: EP-101 12.5 mcg;   Drug: EP-101 25 mcg;   Drug: EP-101 50 mcg;   Drug: EP-101 100 mcg
33 Completed Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
34 Completed A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder;   Drug: FF Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
35 Completed
Has Results 		Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol 150 μg;   Drug: Tiotropium 18 μg;   Drug: Placebo to indacaterol
36 Completed A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719;   Drug: Tiotropium;   Drug: Placebo
37 Recruiting Study of the Efficacy of Home Mechanical Ventilation Post Acute Hypercapnic Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Device: Non invasive ventilation;   Device: LTOT
38 Completed
Has Results 		Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Aclidinium bromide
39 Active, not recruiting WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: New users of ADVAIR DISKUS, ADVAIR HFA (ICS) - containing medications;   Drug: New users of FLOVENT DISKUS, FLVENT HFA (long-acting bronchodilators (LABD))
40 Completed
Has Results 		Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Chronic Obstructive Pulmonary Disease;   Bronchitis;   Emphysema
Interventions: Drug: Arformoterol Tartrate Inhalation Solution;   Drug: Tiotropium;   Drug: Arformoterol and Tiotropium;   Drug: Placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years